Allergan misses in quarter, but 2013 view tops forecasts

Tue Feb 5, 2013 9:10am EST

Feb 5 (Reuters) - Allergan Inc, maker of the Botox anti-wrinkle treatment, reported quarterly earnings below Wall Street forecasts, but projected better-than expected earnings for full-year 2013.

The company on Tuesday said it earned $324 million, or $1.06 per share, in the fourth quarter. That compared with $280 million, or 90 cents per share, in the year-earlier period.

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.